Tech Times on MSN
Artiva shuts NK cell program AlloNK after conditioning chemo kills patient in outpatient trial
Artiva Biotherapeutics permanently discontinues AlloNK, its lead NK cell therapy, after a patient dies of fludarabine-linked ...
HandicapMD introduces park planning guidance for disability parking, the Access Pass, transportation, and visitor ...
An internal memo at Amazon shifted its guidance to software engineers on AI use this week, telling employees to be more ...
Money on MSN
7 best car insurance companies of November 2026
Check out Money’s reviews of the best car insurance companies available to drivers today.
Kyverna Therapeutics advances Miv-cel for autoimmune diseases, but valuation, launch, and funding risks remain. Click here to ...
Eli Lilly’s policy requiring 340B hospitals submit claims-level data in order to receive statutory drug discounts garnered a ...
Mood State Medical expands its Grenco Medical ELITE II vaporiser rollout across Australian pharmacies following ARTG ...
Nasdaq futures rise as chip stocks gain after SK Hynix posted a more than sevenfold jump in quarterly profit. Micron, Nvidia ...
Curbing crime in the city’s most infamous underground market has proven a challenge for city officials, as overdoses outpace ...
Align Technology (NASDAQ:ALGN) reported third-quarter 2026 revenue of $1.015 billion, up 1.9% from a year earlier, as higher clear aligner volumes and international growth helped offset continued ...
If you're looking to refinance—or in some cases buy a new home—a 10-year mortgage might be a good option for you. Here are ...
Boeing, Booking Holdings and Carpenter Technology all set new 52-week lows this week. Despite earnings misses, an FTC probe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results